Jean-Baptiste Assié

5PUBLICATIONS
32CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 24, 2025
Pharmacogenomic Characterization of a Large Cohort of Patient-Derived Cell Lines Identifies Therapeutic Strategies for Pleural Mesothelioma.

Jean-Baptiste Assié, Clément Meiller, Esther Stern

|May 16, 2023
Total Metabolic Tumor Volume on 18F-FDG PET/CT Is a Useful Prognostic Biomarker for Patients with Extensive Small-Cell Lung Cancer Undergoing First-Line Chemo-Immunotherapy.

Julia Grambow-Velilla, Romain-David Seban, Kader Chouahnia

|May 19, 2022
Long-term hospital resource utilization and associated costs of care for patients initiating nivolumab in advanced non-small cell lung cancer in France.

Valentine Grumberg, Christos Chouaïd, François-Emery Cotté

|Mar 25, 2022
Immune-Checkpoint Inhibitors for Malignant Pleural Mesothelioma: A French, Multicenter, Retrospective Real-World Study.

Jean-Baptiste Assié, Florian Crépin, Emmanuel Grolleau

|Feb 03, 2022
Machine Learning-Based Analysis of Treatment Sequences Typology in Advanced Non-Small-Cell Lung Cancer Long-Term Survivors Treated With Nivolumab.

Christos Chouaïd, Valentine Grumberg, Alexandre Batisse

Pageof 1

Frequent Collaborators

4 joint publications

Christos Chouaïd

2 joint publications

Valentine Grumberg

2 joint publications

Anne-Françoise Gaudin

2 joint publications

Francois-Emery Cotté